Nuclear size distinguishes low- from high-grade ovarian serous carcinoma and predicts outcome

Human Pathology

Volumn 36, Issue 10, 2005, Pages 1049-1054

  Hsu, Chih Yi ^a,b,c   Kurman, Robert J ^a   Vang, Russell ^a   Wang, Tian Li ^a   Baak, Jan ^d   Shih, Ie Ming ^a  

^a DEPARTMENT OF PATHOLOGY   (United States)

^b TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^c NATIONAL YANG MING UNIVERSITY   (Taiwan)

^d STAVANGER UNIVERSITY HOSPITAL   (Norway)

Author keywords

Mean nuclear area; Nuclear size; Ovarian serous carcinoma; Volume percentage of epithelium

Indexed keywords

ARTICLE; CANCER CLASSIFICATION; CANCER GRADING; CANCER SURVIVAL; CELL NUCLEUS; COMPUTER PROGRAM; CONTROLLED STUDY; DIAGNOSTIC PROCEDURE; FEMALE; HUMAN; HUMAN TISSUE; MORPHOMETRICS; OVARY CARCINOMA; PREDICTION; PROGNOSIS;

CELL NUCLEUS; CYSTADENOCARCINOMA, SEROUS; DIAGNOSIS, DIFFERENTIAL; FEASIBILITY STUDIES; FEMALE; HUMANS; MICROARRAY ANALYSIS; NEOPLASM STAGING; OVARIAN NEOPLASMS; PROGNOSIS;

EID: 26644442952     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humpath.2005.07.014     Document Type: Article

References (19)

1. J.D. Seidman, I. Horkayne-Szakaly, and M. Haiba The histologic type and stage distribution of ovarian carcinomas of surface epithelial origin Int J Gynecol Pathol 23 2004 41 44
2. A. Malpica, M.T. Deavers, and K. Lu Grading ovarian serous carcinoma using a two-tier system Am J Surg Pathol 28 2004 496 504
3. I.-M. Shih, and R.J. Kurman Ovarian tumorigenesis-a proposed model based on morphological and molecular genetic analysis Am J Pathol 164 2004 1511 1518
4. A.E.S. Sehdev, P.S. Sehdev, and R.J. Kurman Noninvasive and invasive micropapillary serous carcinoma of the ovary: a clinicopathologic analysis of 135 cases Am J Surg Pathol 27 2003 725 736
5. R.E. Bristow, D.R. Gossett, and D.R. Shook Recurrent micropapillary serous ovarian carcinoma Cancer 95 2002 791 800
6. R.E. Bristow, D.R. Gossett, and D.R. Shook Micropapillary serous ovarian carcinoma: surgical management and clinical outcome Gynecol Oncol 86 2002 163 170
7. G. Singer, R. Oldt III, and Y. Cohen Mutations in BRAF and KRAS characterize the development of low-grade ovarian serous carcinoma J Natl Cancer Inst 95 2003 484 486
8. G. Singer, R. Stohr, and L. Cope Patterns of p53 mutations separate ovarian serous borderline tumors and low- and high-grade carcinomas and provide support for a new model of ovarian carcinogenesis: a mutational analysis with immunohistochemical correlation Am J Surg Pathol 29 2005 218 224
9. C.B. Gilks, B.C. Vanderhyden, and S. Zhu Distinction between serous tumors of low malignant potential and serous carcinomas based on global mRNA expression profiling Gynecol Oncol 96 2005 684 694
10. I. Meinhold-Heerlein, D. Bauerschlag, and F. Hilpert Molecular and prognostic distinction between serous ovarian carcinomas of varying grade and malignant potential Oncogene 24 2005 1053 1065
11. J. Brugghe, J.P. Baak, and G.A. Meijer Rapid and reliable assessment of volume percentage of epithelium in borderline and invasive ovarian tumors Anal Quant Cytol Histol 20 1998 14 20
12. E.A. Janssen, J.P. Baak, and M.A. Guervos In lymph node-negative invasive breast carcinomas, specific chromosomal aberrations are strongly associated with high mitotic activity and predict outcome more accurately than grade, tumour diameter, and oestrogen receptor J Pathol 201 2003 555 561
13. J.P. Baak Manual of quantitative pathology in cancer diagnosis and prognosis 1991 Springer-Verlag Berlin
14. J.P. Baak, and E. Janssen DNA ploidy analysis in histopathology. Morphometry and DNA cytometry reproducibility conditions and clinical applications Histopathology 44 2004 603 614
15. M. Brinkhuis, G.A. Meijer, and J.A. Belien Volume-weighted mean nuclear volume and nuclear area in advanced ovarian carcinoma. An investigation of sampling methods, sample size and reproducibility Anal Quant Cytol Histol 17 1995 284 290
16. M. Brinkhuis, J.P. Baak, and G.A. Meijer Value of quantitative pathological variables as prognostic factors in advanced ovarian carcinoma J Clin Pathol 49 1996 142 148
17. G. Singer, R.J. Kurman, and H.-W. Chang Diverse tumorigenic pathways in ovarian serous carcinoma Am J Pathol 160 2002 1223 1228
18. A. Staebler, K. Heselmeyer-Haddad, and K. Bell Micropapillary serous carcinoma of the ovary has distinct patterns of chromosomal imbalances by comparative genomic hybridization compared with atypical proliferative serous tumors and serous carcinomas Hum Pathol 33 2002 47 59
19. D.A. Hill, S. Chiosea, and S. Jamaluddin Inducible changes in cell size and attachment area due to expression of a mutant SWI/SNF chromatin remodeling enzyme J Cell Sci 117 2004 5847 5854